Novel therapy targets blood-clotting proteins to prevent bleeding episodes. The U.S. Food and Drug Administration (FDA) has approved Hympavzi (marstacimab) as a novel treatment for hemophilia. The drug…
Read MoreTreatment
HHS Announces Funding for HIV Medication Assistance
$1.4 billion allotted to help 560,000 patients afford life-saving drug. The Department of Health and Human Services (HHS) announced over $1.4 billion has been allocated to HIV medication…
Read MoreSupreme Court Blocks Title IX Changes
The administration cannot enforce updates to Title IX rule while the case brought by the states is litigated. The U.S. Supreme Court rejected the request from President Biden’s…
Read MoreFDA Authorizes Rapid Point-of-Care Hepatitis C Test
The new testing enables immediate diagnosis and treatment. The U.S. Food and Drug Administration (FDA) granted marketing authorization to Cepheid for the first hepatitis C virus (HCV) test…
Read MoreDistrict Judge Rules Against Marijuana Legality in Massachusetts
He says marijuana companies have grounds to sue if taken to the Supreme Court. District Judge Mark Mastroianni rejected the arguments made by Massachusetts marijuana companies, declaring that…
Read MoreFDA Panel Votes Against First Proposed MDMA-Based Drug
Available data did not show a benefit to the PTSD patients for which it was intended. This week, a Food and Drug Administration (FDA) advisory panel voted against…
Read MoreUSAF Updates Mental Health Rules
New policy intended to expedite the treatment of airmen and prioritize their well-being. The U.S. Air Force has revised its mental health protocols, allowing airmen to pursue treatment…
Read MoreFDA Approves Gene Therapy for Muscular Dystrophy in Children
Treatment is intended for kids with a confirmed mutation of the DMD gene. The U.S. Food and Drug Administration (FDA) recently approved Elevidys, the first gene therapy for…
Read MoreFDA Rejects Antidepressant as COVID Treatment
Request for approval submitted by University of Minnesota professor. The Food and Drug Administration (FDA) published a document last week that declined the emergency use authorization of the…
Read MoreFDA Limits Monoclonal Antibody Therapy
White House dismisses as ineffective treatment against COVID-19. The FDA announced on Monday that it would be limiting the use of monoclonal antibody therapies in treating COVID-19. They…
Read More